|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,184.60 INR | -0.52% |
|
-2.45% | +7.34% |
| 07-22 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 07-22 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 616B 6.45B 5.66B 5.27B 4.85B 9.09B 9.25B 62.56B 24.49B 306B 24.23B 23.7B 1,056B | P/E 2026 |
44.2x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 577B 6.04B 5.3B 4.94B 4.54B 8.51B 8.66B 58.58B 22.93B 286B 22.68B 22.19B 989B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.48x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.52% | ||
| 1 week | -2.45% | ||
| Current month | -0.89% | ||
| 1 month | +1.40% | ||
| 3 months | -6.04% | ||
| 6 months | +9.25% | ||
| Current year | +7.34% |
| 1 week | 2,166 |  | 2,248.8 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | -2.45% | +1.83% | +165.65% | 6.46B | |
| +0.15% | +1.04% | +16.34% | +74.17% | 49.38B | |
| +0.53% | +3.50% | +61.24% | +112.76% | 36.35B | |
| +2.50% | +0.21% | -5.74% | +23.32% | 11.87B | |
| -0.81% | -4.33% | +12.58% | +69.24% | 11.53B | |
| +0.38% | -2.06% | +34.70% | +131.86% | 8.99B | |
| -0.92% | -0.35% | +48.24% | -9.27% | 7B | |
| -0.51% | -0.85% | +11.77% | +33.26% | 6.76B | |
| -1.32% | -11.87% | -32.46% | -0.24% | 5.49B | |
| -1.29% | -3.65% | +20.04% | +115.28% | 4.41B | |
| Average | -0.18% | -1.10% | +16.86% | +71.60% | 14.82B | |
| Weighted average by Cap. | +0.16% | +0.24% | +25.37% | +79.32% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.6B 1.41B 1.31B 1.2B 2.26B 2.3B 15.54B 6.08B 75.93B 6.02B 5.89B 262B | 167B 1.75B 1.53B 1.43B 1.31B 2.46B 2.5B 16.92B 6.62B 82.68B 6.55B 6.41B 286B |
| Net income | 20.53B 215M 189M 176M 162M 303M 308M 2.08B 816M 10.18B 807M 789M 35.18B | 23.28B 244M 214M 199M 183M 343M 349M 2.36B 925M 11.55B 915M 895M 39.89B |
| Net Debt | -39.29B -411M -361M -336M -309M -580M -589M -3.99B -1.56B -19.49B -1.54B -1.51B -67.33B | -37.12B -389M -341M -318M -292M -548M -557M -3.77B -1.47B -18.41B -1.46B -1.43B -63.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | ₹2,184.60 | -0.52% | 490,034 |
| 27/07/26 | ₹2,196.00 | +0.18% | 593,586 |
| 24/07/26 | ₹2,192.00 | -0.59% | 429,562 |
| 23/07/26 | ₹2,205.10 | +0.24% | 567,718 |
| 22/07/26 | ₹2,199.90 | -1.88% | 942,175 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
